Human neural stem cells derived from fetal human brain communicate with each other and rescue ischemic neuronal cells through tunneling nanotubes.
Journal
Cell death & disease
ISSN: 2041-4889
Titre abrégé: Cell Death Dis
Pays: England
ID NLM: 101524092
Informations de publication
Date de publication:
01 Sep 2024
01 Sep 2024
Historique:
received:
30
12
2023
accepted:
15
08
2024
revised:
14
08
2024
medline:
1
9
2024
pubmed:
1
9
2024
entrez:
31
8
2024
Statut:
epublish
Résumé
Pre-clinical trials have demonstrated the neuroprotective effects of transplanted human neural stem cells (hNSCs) during the post-ischemic phase. However, the exact neuroprotective mechanism remains unclear. Tunneling nanotubes (TNTs) are long plasma membrane bridges that physically connect distant cells, enabling the intercellular transfer of mitochondria and contributing to post-ischemic repair processes. Whether hNSCs communicate through TNTs and their role in post-ischemic neuroprotection remains unknown. In this study, non-immortalized hNSC lines derived from fetal human brain tissues were examined to explore these possibilities and assess the post-ischemic neuroprotection potential of these hNSCs. Using Tau-STED super-resolution confocal microscopy, live cell time-lapse fluorescence microscopy, electron microscopy, and direct or non-contact homotypic co-cultures, we demonstrated that hNSCs generate nestin-positive TNTs in both 3D neurospheres and 2D cultures, through which they transfer functional mitochondria. Co-culturing hNSCs with differentiated SH-SY5Y (dSH-SY5Y) revealed heterotypic TNTs allowing mitochondrial transfer from hNSCs to dSH-SY5Y. To investigate the role of heterotypic TNTs in post-ischemic neuroprotection, dSH-SY5Y were subjected to oxygen-glucose deprivation (OGD) followed by reoxygenation (OGD/R) with or without hNSCs in direct or non-contact co-cultures. Compared to normoxia, OGD/R dSH-SY5Y became apoptotic with impaired electrical activity. When OGD/R dSH-SY5Y were co-cultured in direct contact with hNSCs, heterotypic TNTs enabled the transfer of functional mitochondria from hNSCs to OGD/R dSH-SY5Y, rescuing them from apoptosis and restoring the bioelectrical profile toward normoxic dSH-SY5Y. This complete neuroprotection did not occur in the non-contact co-culture. In summary, our data reveal the presence of a functional TNTs network containing nestin within hNSCs, demonstrate the involvement of TNTs in post-ischemic neuroprotection mediated by hNSCs, and highlight the strong efficacy of our hNSC lines in post-ischemic neuroprotection. Human neural stem cells (hNSCs) communicate with each other and rescue ischemic neurons through nestin-positive tunneling nanotubes (TNTs). A Functional mitochondria are exchanged via TNTs between hNSCs. B hNSCs transfer functional mitochondria to ischemic neurons through TNTs, rescuing neurons from ischemia/reperfusion ROS-dependent apoptosis.
Identifiants
pubmed: 39217148
doi: 10.1038/s41419-024-07005-w
pii: 10.1038/s41419-024-07005-w
doi:
Substances chimiques
Tunneling Nanotubes
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
639Informations de copyright
© 2024. The Author(s).
Références
Vieira MS, Santos AK, Vasconcellos R, Goulart VAM, Parreira RC, Kihara AH, et al. Neural stem cell differentiation into mature neurons: mechanisms of regulation and biotechnological applications. Biotechnol Adv. 2018;36:1946–70.
pubmed: 30077716
doi: 10.1016/j.biotechadv.2018.08.002
Hippenmeyer S. Principles of neural stem cell lineage progression: insights from developing cerebral cortex. Curr Opin Neurobiol. 2023;79:102695.
pubmed: 36842274
doi: 10.1016/j.conb.2023.102695
Reynolds BA, Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science. 1992;255:1707–10.
pubmed: 1553558
doi: 10.1126/science.1553558
Mazzini L, Gelati M, Profico DC, Sorarù G, Ferrari D, Copetti M, et al. Results from Phase I Clinical Trial with intraspinal injection of neural stem cells in amyotrophic lateral sclerosis: a long-term outcome. Stem Cells Transl Med. 2019;8:887–97.
pubmed: 31104357
pmcid: 6708070
doi: 10.1002/sctm.18-0154
Mendez I, Sanchez-Pernaute R, Cooper O, Viñuela A, Ferrari D, Björklund L. et al. Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson’s disease. Brain. 2005;128(Part 7):1498–510.
pubmed: 15872020
doi: 10.1093/brain/awh510
Goutman SA, Brown MB, Glass JD, Boulis NM, Johe K, Hazel T, et al. Long-term Phase 1/2 intraspinal stem cell transplantation outcomes in ALS. Ann Clin Transl Neurol. 2018;5:730–40.
pubmed: 29928656
pmcid: 5989736
doi: 10.1002/acn3.567
Mazzini L, Gelati M, Profico DC, Sgaravizzi G, Projetti Pensi M, Muzi G, et al. Human neural stem cell transplantation in ALS: initial results from a phase I trial. J Transl Med. 2015;13:17.
pubmed: 25889343
pmcid: 4359401
doi: 10.1186/s12967-014-0371-2
Hering C, Shetty AK. Extracellular vesicles derived from neural stem cells, astrocytes, and microglia as therapeutics for easing TBI-induced brain dysfunction. Stem Cells Transl Med. 2023;12:140–53.
pubmed: 36847078
pmcid: 10021503
doi: 10.1093/stcltm/szad004
Zhao L, Liu JW, Shi HY, Ma YM. Neural stem cell therapy for brain disease. World J Stem Cells. 2021;13:1278–92.
pubmed: 34630862
pmcid: 8474718
doi: 10.4252/wjsc.v13.i9.1278
Boese AC, Le QSE, Pham D, Hamblin MH, Lee JP. Neural stem cell therapy for subacute and chronic ischemic stroke. Stem Cell Res Ther. 2018;9:154.
pubmed: 29895321
pmcid: 5998588
doi: 10.1186/s13287-018-0913-2
Pastori C, Librizzi L, Breschi GL, Regondi C, Frassoni C, Panzica F, et al. Arterially perfused neurosphere-derived cells distribute outside the ischemic core in a model of transient focal ischemia and reperfusion in vitro. PLoS ONE. 2008;3:e2754.
pubmed: 18648648
pmcid: 2453234
doi: 10.1371/journal.pone.0002754
Sinden JD, Vishnubhatla I, Muir KW. Prospects for stem cell-derived therapy in stroke. Prog Brain Res. 2012;201:119–67.
pubmed: 23186713
doi: 10.1016/B978-0-444-59544-7.00007-X
Huang L, Zhang L. Neural stem cell therapies and hypoxic-ischemic brain injury. Prog Neurobiol. 2019;173:1–17.
pubmed: 29758244
doi: 10.1016/j.pneurobio.2018.05.004
Suda S, Nito C, Yokobori S, Sakamoto Y, Nakajima M, Sowa K, et al. Recent advances in cell-based therapies for ischemic stroke. Int J Mol Sci. 2020;21:6718.
pubmed: 32937754
pmcid: 7555943
doi: 10.3390/ijms21186718
Bacigaluppi M, Pluchino S, Peruzzotti-Jametti L, Kilic E, Kilic U, Salani G, et al. Delayed post-ischaemic neuroprotection following systemic neural stem cell transplantation involves multiple mechanisms. Brain. 2009;132:2239–51.
pubmed: 19617198
doi: 10.1093/brain/awp174
Freed CR, Greene PE, Breeze RE, Tsai WY, DuMouchel W, Kao R, et al. Transplantation of embryonic dopamine neurons for severe Parkinson’s disease. N Engl J Med. 2001;344:710–9.
pubmed: 11236774
doi: 10.1056/NEJM200103083441002
Zhang Q, Li J, An W, Fan Y, Cao Q. Neural stem cell secretome and its role in the treatment of neurodegenerative disorders. J Integr Neurosci. 2020;19:179–85.
pubmed: 32259896
doi: 10.31083/j.jin.2020.01.1142
Willis CM, Nicaise AM, Peruzzotti-Jametti L, Pluchino S. The neural stem cell secretome and its role in brain repair. Brain Res. 2020;1729:146615.
pubmed: 31863730
doi: 10.1016/j.brainres.2019.146615
Marsh SE, Blurton-Jones M. Neural stem cell therapy for neurodegenerative disorders: The role of neurotrophic support. Neurochem Int. 2017;106:94–100.
pubmed: 28219641
pmcid: 5446923
doi: 10.1016/j.neuint.2017.02.006
Doeppner TR, Traut V, Heidenreich A, Kaltwasser B, Bosche B, Bähr M, et al. Conditioned medium derived from neural progenitor cells induces long-term post-ischemic neuroprotection, sustained neurological recovery, neurogenesis, and angiogenesis. Mol Neurobiol. 2017;54:1531–40.
pubmed: 26860410
doi: 10.1007/s12035-016-9748-y
Dause TJ, Denninger JK, Smith BM, Kirby ED. The neural stem cell secretome across neurodevelopment. Exp Neurol. 2022;355:114142.
pubmed: 35709983
doi: 10.1016/j.expneurol.2022.114142
Tkach M, Théry C. Communication by extracellular vesicles: where we are and where we need to go. Cell. 2016;164:1226–32.
pubmed: 26967288
doi: 10.1016/j.cell.2016.01.043
Doeppner TR, Herz J, Görgens A, Schlechter J, Ludwig AK, Radtke S, et al. Extracellular vesicles improve post-stroke neuroregeneration and prevent postischemic immunosuppression. Stem Cells Transl Med. 2015;4:1131–43.
pubmed: 26339036
pmcid: 4572905
doi: 10.5966/sctm.2015-0078
Webb RL, Kaiser EE, Jurgielewicz BJ, Spellicy S, Scoville SL, Thompson TA, et al. Human neural stem cell extracellular vesicles improve recovery in a porcine model of ischemic stroke. Stroke. 2018;49:1248–56.
pubmed: 29650593
pmcid: 5916046
doi: 10.1161/STROKEAHA.117.020353
Kalargyrou AA, Basche M, Hare A, West EL, Smith AJ, Ali RR, et al. Nanotube-like processes facilitate material transfer between photoreceptors. EMBO Rep. 2021;22:e53732.
pubmed: 34494703
pmcid: 8567251
doi: 10.15252/embr.202153732
Cordero Cervantes D, Zurzolo C. Peering into tunneling nanotubes—the path forward. EMBO J. 2021;40:e105789.
pubmed: 33646572
pmcid: 8047439
doi: 10.15252/embj.2020105789
Gerdes HH, Rustom A, Wang X. Tunneling nanotubes, an emerging intercellular communication route in development. Mech Dev. 2013;130:381–7.
pubmed: 23246917
doi: 10.1016/j.mod.2012.11.006
Dupont M, Souriant S, Lugo-Villarino G, Maridonneau-Parini I, Vérollet C. Tunneling nanotubes: intimate communication between myeloid cells. Front Immunol. 2018;9:43.
pubmed: 29422895
pmcid: 5788888
doi: 10.3389/fimmu.2018.00043
Abounit S, Zurzolo C. Wiring through tunneling nanotubes-from electrical signals to organelle transfer. J Cell Sci. 2012;125:1089–98.
pubmed: 22399801
doi: 10.1242/jcs.083279
Ortin-Martinez A, E Yan N, En Leh Samuel T, Lacrimioara C, Akshay G, Nobuhiko T, et al. Photoreceptor nanotubes mediate the in vivoexchange of intracellular material. The EMBO Journal. 2021;40:e107264.
pubmed: 34494680
pmcid: 8591540
doi: 10.15252/embj.2020107264
Liu K, Guo L, Zhou Z, Pan M, Yan C. Mesenchymal stem cells transfer mitochondria into cerebral microvasculature and promote recovery from ischemic stroke. Microvasc Res. 2019;123:74–80.
pubmed: 30611747
doi: 10.1016/j.mvr.2019.01.001
Wang X, Gerdes HH. Transfer of mitochondria via tunneling nanotubes rescues apoptotic PC12 cells. Cell Death Differ. 2015;22:1181–91.
pubmed: 25571977
pmcid: 4572865
doi: 10.1038/cdd.2014.211
Han H, Hu J, Yan Q, Zhu J, Zhu Z, Chen Y, et al. Bone marrow-derived mesenchymal stem cells rescue injured H9c2 cells via transferring intact mitochondria through tunneling nanotubes in an in vitro simulated ischemia/reperfusion model. Mol Med Rep. 2016;13:1517–24.
pubmed: 26718099
doi: 10.3892/mmr.2015.4726
Zou X, Hou Y, Xu J, Zhong L, Zhou J, Zhang G, et al. Mitochondria transfer via tunneling nanotubes is an important mechanism by which CD133+ scattered tubular cells eliminate hypoxic tubular cell injury. Biochem Biophys Res Commun. 2020;522:205–12.
pubmed: 31759629
doi: 10.1016/j.bbrc.2019.11.006
Rasola A, Bernardi P. The mitochondrial permeability transition pore and its involvement in cell death and in disease pathogenesis. Apoptosis. 2007;12:815–33.
pubmed: 17294078
doi: 10.1007/s10495-007-0723-y
Yang Y, Tian Y, Guo X, Li S, Wang W, Shi J. Ischemia Injury induces mPTP opening by reducing Sirt3. Neuroscience. 2021;468:68–74.
pubmed: 34119577
doi: 10.1016/j.neuroscience.2021.06.003
An H, Zhou B, Ji X. Mitochondrial quality control in acute ischemic stroke. J Cereb Blood Flow Metab. 2021;41:3157–70.
pubmed: 34551609
pmcid: 8669286
doi: 10.1177/0271678X211046992
Allen CL, Bayraktutan U. Oxidative stress and its role in the pathogenesis of ischaemic stroke. Int J Stroke. 2009;4:461–70.
pubmed: 19930058
doi: 10.1111/j.1747-4949.2009.00387.x
Bhatia R, Hill MD, Shobha N, Menon B, Bal S, Kochar P, et al. Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action. Stroke. 2010;41:2254–8.
pubmed: 20829513
doi: 10.1161/STROKEAHA.110.592535
Nour M, Scalzo F, Liebeskind DS. Ischemia-reperfusion injury in stroke. Inter Neurol. 2013;1:185–99.
Guo X, Liu R, Jia M, Wang Q, Wu J. Ischemia reperfusion injury induced blood brain barrier dysfunction and the involved molecular mechanism. Neurochem Res. 2023;48:2320–34.
pubmed: 37017889
doi: 10.1007/s11064-023-03923-x
Huang J, Chen L, Yao ZM, Sun XR, Tong XH, Dong SY. The role of mitochondrial dynamics in cerebral ischemia-reperfusion injury. Biomed Pharmacother. 2023;162:114671.
pubmed: 37037094
doi: 10.1016/j.biopha.2023.114671
Mao R, Zong N, Hu Y, Chen Y, Xu Y. Neuronal death mechanisms and therapeutic strategy in ischemic stroke. Neurosci Bull. 2022;38:1229–47.
pubmed: 35513682
pmcid: 9554175
doi: 10.1007/s12264-022-00859-0
Lu M, Guo J, Wu B, Zhou Y, Wu M, Farzaneh M, et al. Mesenchymal stem cell-mediated mitochondrial transfer: a therapeutic approach for ischemic stroke. Transl Stroke Res. 2021;12:212–29.
pubmed: 32975692
doi: 10.1007/s12975-020-00853-6
Chen W, Huang J, Hu Y, Khoshnam SE, Sarkaki A. Mitochondrial transfer as a therapeutic strategy against ischemic stroke. Transl Stroke Res. 2020;11:1214–28.
pubmed: 32592024
doi: 10.1007/s12975-020-00828-7
Huang H, Oo TT, Apaijai N, Chattipakorn N, Chattipakorn SC. An updated review of mitochondrial transplantation as a potential therapeutic strategy against cerebral ischemia and cerebral ischemia/reperfusion injury. Mol Neurobiol. 2023;60:1865–83.
pubmed: 36595193
doi: 10.1007/s12035-022-03200-y
Kaur MM, Sharma DS. Mitochondrial repair as potential pharmacological target in cerebral ischemia. Mitochondrion. 2022;63:23–31.
pubmed: 34999014
doi: 10.1016/j.mito.2022.01.001
Yang Y, Ye G, Zhang YL, He HW, Yu BQ, Hong YM, et al. Transfer of mitochondria from mesenchymal stem cells derived from induced pluripotent stem cells attenuates hypoxia-ischemia-induced mitochondrial dysfunction in PC12 cells. Neural Regen Res. 2020;15:464–72.
pubmed: 31571658
doi: 10.4103/1673-5374.266058
Tan YL, Eng SP, Hafez P, Abdul Karim N, Law JX, Ng MH. Mesenchymal stromal cell mitochondrial transfer as a cell rescue strategy in regenerative medicine: a review of evidence in preclinical models. Stem Cells Transl Med. 2022;11:814–27.
pubmed: 35851922
pmcid: 9397650
doi: 10.1093/stcltm/szac044
Liu K, Ji K, Guo L, Wu W, Lu H, Shan P, et al. Mesenchymal stem cells rescue injured endothelial cells in an in vitro ischemia-reperfusion model via tunneling nanotube like structure-mediated mitochondrial transfer. Microvasc Res. 2014;92:10–8.
pubmed: 24486322
doi: 10.1016/j.mvr.2014.01.008
Gomzikova MO, James V, Rizvanov AA. Mitochondria donation by mesenchymal stem cells: current understanding and mitochondria transplantation strategies. Front Cell Dev Biol. 2021;9:653322.
pubmed: 33898449
pmcid: 8058353
doi: 10.3389/fcell.2021.653322
Profico DC, Gelati M, Ferrari D, Sgaravizzi G, Ricciolini C, Projetti Pensi M, et al. Human neural stem cell-based drug product: clinical and nonclinical characterization. Int J Mol Sci. 2022;23:13425.
pubmed: 36362211
pmcid: 9653902
doi: 10.3390/ijms232113425
Geng Z, Guan S, Wang S, Yu Z, Liu T, Du S, et al. Intercellular mitochondrial transfer in the brain, a new perspective for targeted treatment of central nervous system diseases. CNS Neurosci Ther. 2023;29:3121–35.
pubmed: 37424172
pmcid: 10580346
doi: 10.1111/cns.14344
Berridge MV, Herst PM, Rowe MR, Schneider R, McConnell MJ. Mitochondrial transfer between cells: Methodological constraints in cell culture and animal models. Anal Biochem. 2018;552:75–80.
pubmed: 29158129
doi: 10.1016/j.ab.2017.11.008
Pendergrass W, Wolf N, Poot M. Efficacy of mitotracker green and CMXrosamine to measure changes in mitochondrial membrane potentials in living cells and tissues. Cytometry Part A. 2004;61:162–9.
doi: 10.1002/cyto.a.20033
Stoll EA, Makin R, Sweet IR, Trevelyan AJ, Miwa S, Horner PJ, et al. Neural stem cells in the adult subventricular zone oxidize fatty acids to produce energy and support neurogenic activity. Stem Cells. 2015;33:2306–19.
pubmed: 25919237
doi: 10.1002/stem.2042
Mihaylova MM, Cheng CW, Cao AQ, Tripathi S, Mana MD, Bauer-Rowe KE, et al. Fasting activates fatty acid oxidation to enhance intestinal stem cell function during homeostasis and aging. Cell Stem Cell. 2018;22:769–78.e4.
pubmed: 29727683
pmcid: 5940005
doi: 10.1016/j.stem.2018.04.001
Knobloch M, Pilz GA, Ghesquière B, Kovacs WJ, Wegleiter T, Moore DL, et al. A fatty acid oxidation-dependent metabolic shift regulates adult neural stem cell activity. Cell Rep. 2017;20:2144–55.
pubmed: 28854364
pmcid: 5583518
doi: 10.1016/j.celrep.2017.08.029
Whitehead J, Zhang J, Harvestine JN, Kothambawala A, Liu GY, Leach JK. Tunneling nanotubes mediate the expression of senescence markers in mesenchymal stem/stromal cell spheroids. Stem Cells. 2020;38:80–9.
pubmed: 31298767
doi: 10.1002/stem.3056
Zhang J, Whitehead J, Liu Y, Yang Q, Leach JK, Liu GY. Direct observation of tunneling nanotubes within human mesenchymal stem cell spheroids. J Phys Chem B. 2018;122:9920–6.
pubmed: 30350968
doi: 10.1021/acs.jpcb.8b07305
Steinert PM, Chou YH, Prahlad V, Parry DA, Marekov LN, Wu KC, et al. A high molecular weight intermediate filament-associated protein in BHK-21 cells is nestin, a type VI intermediate filament protein. Limited co-assembly in vitro to form heteropolymers with type III vimentin and type IV alpha-internexin. J Biol Chem. 1999;274:9881–90.
pubmed: 10092680
doi: 10.1074/jbc.274.14.9881
Eliasson C, Sahlgren C, Berthold CH, Stakeberg J, Celis JE, Betsholtz C, et al. Intermediate filament protein partnership in astrocytes. J Biol Chem. 1999;274:23996–4006.
pubmed: 10446168
doi: 10.1074/jbc.274.34.23996
Bokhari AA, Baker TM, Dorjbal B, Waheed S, Zahn CM, Hamilton CA, et al. Nestin suppression attenuates invasive potential of endometrial cancer cells by downregulating TGF-β signaling pathway. Oncotarget. 2016;7:69733–48.
pubmed: 27626172
pmcid: 5342511
doi: 10.18632/oncotarget.11947
Bernal A, Arranz L. Nestin-expressing progenitor cells: function, identity and therapeutic implications. Cell Mol Life Sci. 2018;75:2177–95.
pubmed: 29541793
pmcid: 5948302
doi: 10.1007/s00018-018-2794-z
Uzdensky AB. Apoptosis regulation in the penumbra after ischemic stroke: expression of pro- and antiapoptotic proteins. Apoptosis. 2019;24:687–702.
pubmed: 31256300
doi: 10.1007/s10495-019-01556-6
Kokaia Z, Darsalia V. Neural stem cell-based therapy for ischemic stroke. Transl Stroke Res. 2011;2:272–8.
pubmed: 24323649
doi: 10.1007/s12975-011-0100-6
Richards LG, Cramer SC. Advances in stroke: therapies targeting stroke recovery. Stroke. 2021;52:348–50.
pubmed: 33349022
doi: 10.1161/STROKEAHA.120.033231
Park YJ, Niizuma K, Mokin M, Dezawa M, Borlongan CV. Cell-based therapy for stroke: musing with muse cells. Stroke. 2020;51:2854–62.
pubmed: 32811374
doi: 10.1161/STROKEAHA.120.030618
Wang F, Tang H, Zhu J, Zhang JH. Transplanting mesenchymal stem cells for treatment of ischemic stroke. Cell Transpl. 2018;27:1825–34.
doi: 10.1177/0963689718795424
Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367:eaau6977.
pubmed: 32029601
pmcid: 7717626
doi: 10.1126/science.aau6977
Borcherding N, Brestoff JR. The power and potential of mitochondria transfer. Nature. 2023;623:283–91.
pubmed: 37938702
doi: 10.1038/s41586-023-06537-z
Jäderstad J, Jäderstad LM, Li J, Chintawar S, Salto C, Pandolfo M, et al. Communication via gap junctions underlies early functional and beneficial interactions between grafted neural stem cells and the host. Proc Natl Acad Sci USA. 2010;107:5184–9.
pubmed: 20147621
pmcid: 2841882
doi: 10.1073/pnas.0915134107
Sartori-Rupp A, Cordero Cervantes D, Pepe A, Gousset K, Delage E, Corroyer-Dulmont S, et al. Correlative cryo-electron microscopy reveals the structure of TNTs in neuronal cells. Nat Commun. 2019;10:342.
pubmed: 30664666
pmcid: 6341166
doi: 10.1038/s41467-018-08178-7
Azevedo-Pereira RL, Manley NC, Dong C, Zhang Y, Lee AG, Zatulovskaia Y, et al. Decoding the molecular crosstalk between grafted stem cells and the stroke-injured brain. Cell Rep. 2023;42:112353.
pubmed: 37043353
pmcid: 10562513
doi: 10.1016/j.celrep.2023.112353
Driscoll J, Gondaliya P, Patel T. Tunneling nanotube-mediated communication: a mechanism of intercellular nucleic acid transfer. Int J Mol Sci. 2022;23:5487.
pubmed: 35628298
pmcid: 9143920
doi: 10.3390/ijms23105487
Gritti A, Frölichsthal-Schoeller P, Galli R, Parati EA, Cova L, Pagano SF et al. Epidermal and fibroblast growth factors behave as mitogenic regulators for a single multipotent stem cell-like population from the subventricular region of the adult mouse forebrain. J Neurosci. 1999;19:3287–97. https://www.jneurosci.org/content/19/9/3287 .
Korecka JA, van Kesteren RE, Blaas E, Spitzer SO, Kamstra JH, Smit AB, et al. Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling. PLoS ONE. 2013;8:e63862.
pubmed: 23724009
pmcid: 3665836
doi: 10.1371/journal.pone.0063862
Şahin M, Öncü G, Yılmaz MA, Özkan D, Saybaşılı H. Transformation of SH-SY5Y cell line into neuron-like cells: investigation of electrophysiological and biomechanical changes. Neurosci Lett. 2021;745:135628. https://www.sciencedirect.com/science/article/pii/S0304394021000069 .